Reports by Industry

Diagnostics Market Reports

Global Cardiac Biomarkers Market Size, Trends & Analysis - Forecasts to 2026 By Type (Troponin (T And I), Myocardial Muscle Creatine Kinase (CK-MB), Natriuretic Peptides [B-Type Natriuretic Peptide (BNP) & N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP)], Ischemia Modified Albumin (IMA), Myoglobin, Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others), By Location Of Testing (Laboratory Testing, Point Of Care (POC) Testing); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis; By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global cardiac biomarkers market is estimated to be valued at USD 12.34 billion in 2021 and is projected to reach USD 27.58 billion by 2026 at a CAGR of 17.45%. There has been an increase in the proportion of patients enduring acute coronary syndrome (ACS) in recent years, creating a global demand for cardiac marker diagnostics. Read More »
July 13 : 2021

Global Veterinary Diagnostics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Consumables, Instruments), By Animal Type (Companion Animals, Livestock), By Technology (Molecular Diagnostics, Hematology, Immunodiagnostics, Clinical Biochemistry, Urinalysis, Other Veterinary Diagnostic Technologies), By End-User (Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-Care/ In-House Testing, Veterinary Research Institutes & Universities), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global veterinary diagnostics market will grow from USD 2.3 billion in 2021 to reach USD 4.1 billion in 2026, with a CAGR of 9.1% during the forecast period. The veterinary laboratory provides a secure environment for conducting medical tests on infectious agents or toxicity found in animal diagnostic samples. Read More »
July 13 : 2021

Global Leukemia Market Size, Trends & Analysis - Forecasts to 2026 By Type (Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia), By Treatment Type (Chemotherapy, Targeted Drugs & Immunotherapy), By Molecule Type (Biologics, Small Molecules), By Mode of Administration (Oral Mode, Injectable Mode), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global leukemia market will grow from USD 13.21 billion in 2021 to reach USD 19.52 billion in 2026, with a CAGR of 6.52% from 2021 to 2026. Leukemia is a rapidly spreading blood cancer that occurs in the bone marrow and progresses to uncontrolled blood cell development. Read More »
July 13 : 2021

Global Cancer Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centre), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global cancer therapeutics market will grow from USD 140.22 billion in 2021 to reach USD 230.12 billion in 2026, with a CAGR of 8.52% from 2021 to 2026. Cancer therapies are described as techniques that deliver target-specific drugs to cancer cells to prevent or stop the growth of tumors that cause cell death. Read More »
July 13 : 2021

Global End-Stage Renal Disease Market Size, Trends & Analysis - Forecasts to 2026 By Disease Type (Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Failure) By Treatment (Transplant, Dialysis [Peritoneal Dialysis, Hemodialysis, Wearable Artificial Kidney]), By Region (North America, Europe, Asia Pacific, MEA, and CSA), End-User Landscape, Company Market Share Analysis, and Competitor Analysis

The global end-stage renal disease market size is projected to grow from USD 74.01 billion in 2021 to USD 144.09 billion by 2026 at a CAGR value of 12.1%. The end-stage renal disease (ESRD) market is predicted to be driven by a spike in the number of kidney failure sufferers and the development of technologically improved medical devices and equipment such as minimal dialysis equipment and artificial kidneys. Read More »
July 6 : 2021

Global Non-Invasive Aesthetic Treatment Market Size, Trends & Analysis - Forecasts to 2026 By Procedure (Injectables [Botulinum Toxin, Calcium Hydroxylapatite, Hyaluronic Acid, Polymer Filler, Collagen], Skin Rejuvenation [Chemical Peel, Laser Skin Resurfacing, Photo Rejuvenation], Others [Hair Removal, Non-Surgical Fat Reduction, Sclerotherapy, Cellulite Treatment]), By End User (Hospitals & Clinics, Dermatology Clinics & Cosmetic Centers and Salons & Spas), By Region (North America, Europe, Asia Pacific, MEA, and CSA), End-User Landscape, Company Market Share Analysis, and Competitor Analysis

The global non-invasive aesthetic treatment market size is projected to grow from USD 4.60 billion in 2021 to USD 9.45 billion by 2026 at a CAGR value of 13.1%. The increasing number of non-invasive aesthetic/cosmetic treatments performed each year, rising consumer awareness of non-invasive and painless cosmetic treatments, and the increasing availability of technologically advanced and sophisticated medical devices are the primary drivers supporting the growth of the non-invasive aesthetic treatment market. Read More »
July 6 : 2021

Global Ovarian Cancer Diagnostics Market Size, Trends, and Analysis - Forecasts to 2026 By Diagnosis (Imaging [Ultrasound, CT scan, MRI Scan, PET Scan, Others], Blood Test [CA125, HER2, BRCA, CEA, ER & PR, KRAS Mutation, Others], Biopsy, Others), By Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell, Others), By End-Use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global ovarian cancer diagnostics market is projected to grow from USD 25.0 billion in 2021 to USD 36.5 billion by 2026 at a CAGR value of 7.5%. Factors like the rising prevalence of ovarian cancer, rising consumption of unhealthy foods, increasing chronic disorders related to the reproductive organ, technological advancements in cancer diagnosis, rising awareness regarding pre-disease diagnosis and other health concerns, non-invasive nature of the technique to detect the tumor will help the market grow rapidly from 2021 to 2026. Read More »
July 5 : 2021

Global Infectious Disease Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, and HPV infection), By Mode of Treatment (Drugs, Vaccines), By Drug Class (Anti-Bacterial, Anti-Viral, Anti-Parasite, Anti-Fungal, Others), By End-User (Hospital Pharmacy, Retail Pharmacy, Others), By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The global infectious disease therapeutics market is expected to grow from USD 48.77 billion in 2021 to USD 57.21 billion in 2026, at a CAGR of 7.12%. The market drivers which contribute to the infectious disease therapeutics market growth include rising infectious disease, an increasing number of surgeries, high prevalence of chronic diseases such as cardiovascular and cancer, rising cases of accidents, changing food habits, lack of proper sanitation measures taken by healthcare providers, and personal unhygienic conditions, lack of antibodies & immunity, and growing patient pool. Read More »
July 2 : 2021

Global Point of Care Diagnostics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Drugs-of-abuse Testing Products, Cholesterol Testing Products, and Other POC Products), By Platform (Lateral Flow Assays, Immunoassays, Microfluidics, Molecular Diagnostics and Dipsticks), By Mode of Purchase (Prescription, Over The Counter (OTC)), By End-User (Outpatient & Ambulatory Care Facilities, Hospitals & Critical Care Centers, Home Care Settings, and Other End Users), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The global point of care diagnostics market size is projected to grow from USD 29.5 billion in 2021 to USD 50.6 billion by 2026 at a CAGR value of 11.4%. Technological advancements in diagnostic medicine have been the major driver of the POC diagnostics market. Read More »
July 2 : 2021

Global Comprehensive Metabolic Panel Testing Market Size, Trends, and Analysis - Forecasts To 2026 By Disease (Kidney Disease, Liver Disease, Diabetes, Others), By End-Use (Laboratories, PoC), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global comprehensive metabolic panel testing market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Increasing prevalence of cardiovascular diseases and diabetes, the emergence of automated systems in laboratories, efficient and rapid results, development of data management solutions and introduction of innovative solutions for enhancing efficiency and minimizing errors are expected to increase demand for the comprehensive metabolic panel testing market. Read More »
July 2 : 2021